SUNZEN Share Price Performance
RM 0.28
-0.04 (-12.70%)
44.7% overvalued intrinsic discount
RM 0.19
Fair Value
Price RM 0.28
Ontological RM 0.19
Fair ValueRM 0.47
Share Pricen/a
Sunzen Group Berhad Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
SUNZEN Community Narratives
ON
Fair Value RM 0.47 41.5% undervalued intrinsic discount
Sunzen Biotech Positive Performance
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Sunzen Biotech Positive Performance
Sunzen Biotech Berhad: Q1 FY25 Financial Insights and Technical Outlook Financial Performance Overview Sunzen Biotech Berhad posted a stable financial performance for Q1 FY25, achieving a revenue of RM22.96 million, an 11.42% increase compared to the preceding quarter. Key contributors were: • Human Health Segment: RM17.65 million in revenue, driven by robust export sales of edible bird’s nests to China, constituting 79.32% of segment revenue.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
ON
RM 0.47
41.5% undervalued intrinsic discount
Ontological Fair Value
Revenue growth
18% p.a.
Profit Margin
6.34%
Future PE
40.14x
Share price in 2029
RM 0.74
Snowflake Analysis
Sunzen Group Berhad Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- 0.0034
- 31.02%
- 3.21%
- 12.6%
About SUNZEN
- Founded
- 1998
- Employees
- 168
- CEO
- WebsiteView website
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells traditional Chinese medicine; trades in crude palm oil and derivative products; and manufactures, imports, trades in, exports, and sells bird’s nests and related products. In addition, the company retails herbal drinks, foodstuffs, hampers, and related health products. Further, it engages in the wholesale and trading of animal health and nutrition products for livestock, animal beauty, and cosmetic products; and retail, wholesale, distribution, and trading of health and herbal products, as well as manufacturing, trading, marketing, e-commerce, sales of food and beverage nutrition products. Additionally, the company trades in ophthalmic and diagnostic equipment and other related products. The company was formerly known as Sunzen Biotech Berhad and changed its name to Sunzen Group Berhad in December 2024. Sunzen Group Berhad was founded in 1998 and is based in Shah Alam, Malaysia.
